Ladiasan, Modashier B.

HRN: 28-83-48  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/01/2026
MUPIROCIN 2%, 15G (TUBE)
05/01/2026
05/01/2026
TOPICAL
Topical
Now
Burn, Scald
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: